- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04776057
Rotation Stability of Toric Intraocularlens (IOL) Compared Sitting Against Lying After Cataract Operation
October 12, 2022 updated by: Prim. Prof. Dr. Oliver Findl, MBA
To assess the rotation stability of toric intraocular lenses between sitting or routine settings (sitting, going around) after cataract operation.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
To assess the rotation stability of toric intraocular lenses between sitting or routine settings (sitting, going around) after cataract operation.
Study Type
Interventional
Enrollment (Anticipated)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Julius Hienert, MD
- Phone Number: +436646415113
- Email: j.hienert@viros.at
Study Locations
-
-
-
Vienna, Austria, 1140
- Recruiting
- Hanusch Hospital, Department of Ophthalmology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Cataract
- Age 21 and older
- Regular corneal astigmatism ≥ 1.5 D
- written informed consent prior to surgery
Exclusion Criteria:
- Relevant other ophthalmic diseases such as: pseudoexfoliation, traumatic cataract corneal scars, and other co-morbidity that could affect capsule bag stability ( e.g. Marfan syndrome)
- High myopia (> 29 mm AL)
- Irregular corneal astigmatism on corneal topography
- In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: lying
after cataract lying for 1 hour
|
rotation stability of toric intraocular lenses between sitting or routine settings (sitting, going around) after cataract operation
|
|
OTHER: sitting, walkin
after cataract sitting or walking for 1 hour
|
rotation stability of toric intraocular lenses between sitting or routine settings (sitting, going around) after cataract operation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison of toric IOL rotation between both groups (mean ≠ SD)
Time Frame: 1 Year
|
Aim is to see if the lying down after the operation lowers the risk of toric IOL rotation compared to sitting down
|
1 Year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2021
Primary Completion (ANTICIPATED)
December 30, 2023
Study Completion (ANTICIPATED)
December 30, 2023
Study Registration Dates
First Submitted
February 25, 2021
First Submitted That Met QC Criteria
February 25, 2021
First Posted (ACTUAL)
March 1, 2021
Study Record Updates
Last Update Posted (ACTUAL)
October 13, 2022
Last Update Submitted That Met QC Criteria
October 12, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EK 20-302-1220
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ziemer Ophthalmic Systems AGTigermed Consulting Co., LtdRecruitingMyopic AstigmatismChina
-
Bausch & Lomb IncorporatedCompleted
-
CooperVision, Inc.CompletedAstigmatism BilateralCanada
-
University Clinic FrankfurtCompleted
Clinical Trials on catarct surgery with toric intra ocular lenses
-
Indonesia UniversityCompleted
-
Kevin BarberAlcon Research; Eric Rosenberg, D.O.,M.Sc.Eng.Completed
-
CIBA VISIONCompletedRefractive Error | Astigmatism | Myopia
-
Western Sussex Hospitals NHS TrustRayner Intraocular Lenses LtdUnknownCataract | AstigmatismUnited Kingdom
-
Alcon ResearchCompleted
-
Wenzhou Medical UniversityNot yet recruitingCataract | Corneal Astigmatism
-
Kagawa UniversityUnknownCataract | Corneal Astigmatism | Epiretinal MembraneJapan
-
Alcon ResearchCompletedAstigmatism | Myopia | Hyperopia | AmetropiaUnited States